We Are Solutions...On Demand
Item #: 126-11
Form:
Lyophilized from 0.02M NH4HCO3
Purity:
>98% by SDS-PAGE
Cat. No:
126-11
Molecular Weight:
11800
Product Name:
BETA 2 MICROGLOBULIN
Expiration:
2 years
UNSPSC code:
51131907
Storage:
2-8 C
UNSPSC code:
51131907
Source:
Human Urine
Synonyms:
B2M, BMG
Human Beta 2 Microglobulin(B2M) protein BULK QUANTITIES from 100-5000 mg. Custom fills for Human Beta 2-microglobulin (B2M) available. LeeBio can provide custom buffers for Human Beta 2-microglobulin (B2M)and private labeling for beta 2 microglobulin.
Serum beta2-microglobulin, an endogenous marker for renal function, has been shown to be an independent predictor of mortality in older adults.Beta-2-microglobulin, also known as B2M, is a secreted protein which belongs to the beta-2-microglobulin family. It contains one Ig-like C1-type (immunoglobulin-like) domain. Beta-2 microglobulin (B2M) plays a pivotal role in the biology of mammals
Bulk producer and manufacturer Lee Biosolutions will custom purify to your specifications. No job too small. Beta 2 microglobulin levels can rise either because its rate of synthesis has increased (e.g. in AIDS, malignant monoclonal plasma cell dyscrasia, solid tumours and autoimmune disease) or because of impaired renal filtration (e.g. due to renal insufficiency, graft rejection or nephrotoxicity induced by post-transplantation immunosuppressive therapy).
B2M association with major histocompatibility complex (MHC) Class I gene products. The latter molecules have been shown to affect reproduction in both mice and humans. B2M forms the small invariable light chain subunit of class I HLA antigens on the cell membrane of all nucleated cells. During the continuous turnover of the HLA molecules. B2M is shed from the cell membrane into blood. Lymphocytes are the main source of serum free B2M. Serum B2M concentration is increased in renal diseases, various malignant diseases and some inflammatory and autoimmune disorders. In lymphatic malignancies serum B2M has significant prognostic value. B2M has been shown as a marker for monitoring inflammatory disease activity and it appears likely to have a destructive role in amyloidosis-related arthritis. B2M might be involved in the OA (osteoarthritis ) pathogenesis. Defects in B2M are the cause of hypercatabolic hypoproteinemia. Affected individuals show marked reduction in serum concentrations of immunoglobulin and albumin, probably due to rapid degradation. B2M could be a potential therapeutic target in ovarian cancer.